A precision-medicine TechBio company
From Spatial Insights to Life-Changing Medicines
ABOUT PORTRAI
From Spatial Insights to Life-Changing Medicines
Founded in 2021 by four Seoul National University medical researchers, Portrai fuses spatial biology and AI to make drug development data-driven rather than hypothesis-driven. Our goal is to lead the industry toward deeper precision medicine.
- FOUNDED
- 2021
- HQ
- Seoul, Korea
- US OFFICE
- Cambridge, MA
- TEAM
- 26
LEADERSHIP
Leadership.
Portrai's leadership brings together spatial biology, clinical oncology, and AI research.
-
Daeseung Lee
Chief Executive Officer
Physician-scientist who left clinical practice to bring spatial biology into oncology drug discovery.
LinkedIn -
Hongyoon Choi
Chief Technology Officer
Builds the algorithms that turn spatial transcriptomics into actionable target intelligence.
LinkedIn -
Hyung-Jun Im
Chief Scientific Officer
Nuclear medicine specialist linking imaging biomarkers to next-generation radiopharmaceuticals.
LinkedIn -
Kwonjoong Na
Chief Medical Officer
Translates platform insights into IND-enabling decisions across oncology programs.
LinkedIn
MEDIA KIT
Press & media resources
Download the Portrai logo and company profile for press coverage and partnership decks.
GET IN TOUCH
Get in touch.
Whether you are looking to co-discover novel targets, license our assets, or engineer the future with us, we are ready to connect.